Form D · Biotechnology

PRIME GENOMICS, INC.

San Francisco, CA · CIK 0001537877

Offering snapshot reported Dec 31, 2014 · SEC filing

Reported sold: $804K
Investors reported: 17
Minimum accepted: $2.5K
First sale: Nov 27, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$324,685 → $803,600
Reported investors8 → 17

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 31, 2014	Amendment	$803,600	$478,915vs Jan 14, 2014	17	SEC filing
Jan 14, 2014	Amendment	$324,685	$304,685vs Dec 5, 2012	8	SEC filing
Dec 5, 2012	Initial	$20,000	No comparison	2	SEC filing
Dec 27, 2011	Initial	$192,000	No comparison	4	SEC filing

Offering details

Securities: Debt, Option to acquire
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-187919

NONE - NOT APPLICABLE

Source: Form D, filed Dec 31, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Alan Brimm	Promoter
Scott Greenstone	Director
Peter V. Groetzinger	Promoter
Thomas W Loker	Executive
Sandy C. Shaw	Director, Executive, Promoter
Robert R. Tufts	Director, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:

111 Commonwealth
San Francisco, CA, 94118